Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
8.44
+0.44 (5.50%)
Mar 4, 2026, 4:00 PM EST - Market closed
Passage Bio Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Passage Bio stock have an average target of 23.5, with a low estimate of 10 and a high estimate of 40. The average target predicts an increase of 178.44% from the current stock price of 8.44.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Passage Bio stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $67 → $23 | Strong Buy | Maintains | $67 → $23 | +172.51% | Mar 4, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $6 → $21 | Strong Buy | Maintains | $6 → $21 | +148.82% | Nov 12, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $260 → $67 | Strong Buy | Maintains | $260 → $67 | +693.84% | Aug 14, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $40 → $10 | Strong Buy | Maintains | $40 → $10 | +18.48% | Aug 14, 2025 |
| Wedbush | Wedbush | Buy Maintains $3 → $40 | Buy | Maintains | $3 → $40 | +373.93% | Aug 13, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-5.04
from -14.35
EPS Next Year
-3.64
from -5.04
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | n/a | n/a | |||
| Avg | n/a | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -3.35 | -1.51 | |||
| Avg | -5.04 | -3.64 | |||
| Low | -7.35 | -5.52 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.